Login

Glaxosmithkline Pharmaceuticals Ltd.

₹3291.6

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Glaxosmithkline Pharmaceuticals Ltd.

₹3291.6

₹3291.6

-17.4 (-0.53%) - 10 Jul 2025 10:21 AM

About Company

Glaxosmithkline Pharmaceuticals Limited is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.

Market Cap. ₹ 56,056 Cr.
52 Week - High/Low ₹ 3,516/1,921
P/E Ratio 61.00
P/B Ratio 28.76
Enterprise Value -
ROE % 48.92
RSI Value 51.80
EMA 50 3159.78
EMA 200 2752.57
Market Cap. ₹ 56,056 Cr.
52 Week - High/Low ₹ 3,516/1,921
P/E Ratio 60.44
P/B Ratio 28.73
Enterprise Value -
ROE % 49.43
RSI Value 51.80
EMA 50 3159.78
EMA 200 2752.57
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.